MetroHealth CRS

Cleveland, Ohio 441091998

0 studies enrolling now · 43 studies all time

What they study most

AIDS-Associated Nephropathy, Cytomegalovirus Infections, HIV Infection, HIV Infections, HIV-1 Infections, Hepatitis B, Hepatitis C, Hepatitis C Infection, Herpes Zoster, Lipoatrophy, Lipodystrophy, Liver Disease

Studies at this site

• Effectiveness of and Immune Response to HIV Vaccination Followed by Treatment Interruption in HIV Infected Patients — Completed
• Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV) — Completed
• Gradual Initiation of Sulfamethoxazole/Trimethoprim as Primary Pneumocystis Carinii Pneumonia Prophylaxis — Completed
• Antiviral Activity of and Resistance to Lamivudine in Combination With Zidovudine, Stavudine, or Didanosine — Completed
• Evaluating the Effectiveness of Boceprevir, Pegylated-Interferon Alfa 2b and Ribavirin in Treating Hepatitis C Virus (HCV) Infection in Adults With HIV and HCV Infection — Completed
• A Randomized, Comparative Study of Daily Dapsone and Daily Atovaquone for Prophylaxis Against PCP in HIV-Infected Patients Who Are Intolerant of Trimethoprim and/or Sulfonamides — Completed
• Cyclosporine A in Combination With Abacavir Sulfate, Lamivudine, and Zidovudine and Lopinavir/Ritonavir in HIV — Completed
• Safety, Tolerability and Immune Response to LC002, an Experimental Therapeutic Vaccine, in Adults Receiving HAART — Completed
• Effects of a Uridine Supplement on HIV Infected Adults With Lipoatrophy — Completed
• Effectiveness of Palifermin in Increasing CD4 Counts in Treatment-Experienced HIV Infected Adults — Completed
• Effect of Addition of Raltegravir (MK-0518) to PI- or NNRTI-Based ART Regimens in HIV Infected Subjects With Undetectable Viral Load — Completed
• Optimizing Treatment for Treatment-Experienced, HIV-Infected People — Completed
• Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women — Completed
• Live Zoster Vaccine in HIV-Infected Adults on Antiretroviral Therapy — Completed
• Combination Pain Therapy in HIV Neuropathy — Stopped early
• Nitazoxanide Plus Ribavirin and Peginterferon for Therapy of Treatment Naive HCV Genotype 1 and HIV Coinfected Subjects — Completed
• A Randomized, Double-Blind Phase II/III Trial of Monotherapy vs. Combination Therapy With Nucleoside Analogs in HIV-Infected Persons With CD4 Cells of 200-500/mm3 — Completed
• Interleukin-2 (IL-2) Treatment for HIV Infected Patients Who Have Interrupted Their Anti-HIV Drug Therapy — Completed
• Comparing the Safety, Effectiveness, and Tolerability of Three Anti-HIV Drug Regimens for Treatment-Naive Patients — Completed
• Administration of Growth Hormone to Increase CD4+ Count in Patients Taking Anti-HIV Drugs — Completed
• A Study to Compare Anti-HIV Drugs Given Twice a Day or Once a Day, With or Without Direct Observation — Completed
• Safety and Effectiveness of the Oral HIV Entry Inhibitor Vicriviroc in HIV Infected Patients — Completed
• Safety of Interleukin-7 in HIV Infected People Currently Taking Anti-HIV Drugs — Completed
• Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF) — Completed
• Determining Responses to Two Different Vaccines in HIV and HCV Infected Individuals — Completed
• The Safety and Effectiveness of Clarithromycin and Rifabutin Used Alone or in Combination to Prevent Mycobacterium Avium Complex (MAC) or Disseminated MAC Disease in HIV-Infected Patients — Completed
• A Study of HIV-Disease Development in Aging — Completed
• Preventing Cytomegalovirus (CMV) Organ Damage With Valganciclovir in People With HIV — Completed
• Effect of Interleukin-2 on HIV Treatment Interruption — Completed
• Combination Treatment With and Without Protease Inhibitors for Women Who Begin Therapy for HIV Infection During Pregnancy — Completed
• Dual Versus Triple Protease Inhibitor Combinations, Including Ritonavir, in HIV Infected People — Completed
• A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV — Completed
• A Phase II Randomized, Double-Blind, Placebo-Controlled Trial to Determine the Efficacy of Prednisone Therapy in HIV-Associated Nephropathy (HIVAN) — Completed
• A Study of the Safety and Effectiveness of Hydroxyurea in Patients on Potent Antiretroviral Therapy and Who Have Less Than 200 Copies/ml of HIV RNA in Their Blood — Completed
• Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected Individuals — Completed
• Safety and Effectiveness of Raltegravir Plus Darunavir/Ritonavir in Treatment-Naive HIV-Infected Adults — Completed
• Telephone Support to Improve Adherence to Anti-HIV Medications — Stopped early
• Impact of Antiretroviral Therapy on Metabolic, Skeletal, and Cardiovascular Parameters — Completed
• Differences in Blood Levels of Lopinavir/Ritonavir in HIV Infected Men and Women — Completed
• Comparative Study of Three NNRTI-Sparing HAART Regimens — Completed
• Effects of Treatment Changes on Fat Wasting in the Arms and Legs of HIV Patients — Completed
• Addition of Efavirenz or Nelfinavir to a Lamivudine/Zidovudine/Indinavir HIV Treatment Regimen — Completed
• Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection — Completed